| | Moderna Inc has made all necessary submissions required by the U.S. Food & Drug Administration for emergency use authorization of its COVID-19 vaccine in adolescents and children, it said on Wednesday. | | | A shortage of dye for medical scans produced by General Electric's healthcare unit in China is affecting regions beyond the United States with a German hospital warned of a supply squeeze. | | | The fresh blow to Roche's hopes in a closely watched class of cancer immunotherapies cast a long shadow across the crowded field on Wednesday, but the latest setback is not the end of the road for these oncology treatments, analysts say. | | | Abbott Laboratories said on Wednesday it could restart production of infant formula at its troubled Michigan facility within two weeks. | | | In New York, lawmakers have introduced a bill to expand funding for abortion care. California legislators will soon vote on measures aimed at increasing the number of abortion providers. And Connecticut just enacted a law aimed at protecting providers from lawsuits in states where abortion is banned. | | | Greece on Wednesday banned conversion therapy for minors, a practice aimed at suppressing a person's sexual orientation or gender identity and which the lesbian, gay, bisexual and trans community worldwide, as well as health experts, have condemned as harmful. | | | Arkansas's attorney general on Wednesday accused drugmakers and pharmacy benefit managers of colluding to drive up the price of insulin drugs, the latest in a series of lawsuits to take aim at skyrocketing costs for the life-sustaining medicine. | | | Pfizer Inc's $11.6 billion deal for migraine specialist Biohaven Pharmaceutical has kindled expectations on Wall Street that it may usher in more buyouts as cash-flush drugmakers look to snap up beaten-down smaller biotechs. | | | South Africa's National Institute for Communicable Diseases on Wednesday reported 10,017 new COVID-19 cases, the first day since January the institute has reported more than 10,000 new infections. | | | Moderna Inc's chief financial officer, Jorge Gomez, departed a day after taking charge, the vaccine maker said on Wednesday, following his former employer disclosing an internal probe related to financial reporting. | | | | |